October 18, 2021 in Client News

Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain

Avance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the news that its client XWPharma Ltd. has announced dosing of subjects in its first-in-human study…
Read More
August 10, 2021 in Company Awards, Company News

Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award for Customer Value Leadership

Avance Clinical, the largest premium Australian CRO for international biotechs, has been awarded the prestigious Frost & Sullivan 2021 Asia-Pacific CRO Customer Value Leadership Award, the second consecutive Asia-Pacific (APAC)…
Read More
July 9, 2021 in Client News, Company News

Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia

The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client Tetherex Pharmaceuticals on first patient dosing for…
Read More
July 9, 2021 in Client News

Avance Clinical Client XWPharma Announces Positive Results from Phase 1 Clinical Trials of XW10172, in Development as Once-Nightly Therapy for Sleep Disorders in Patients with Neurodegenerative Diseases

The leading Australian CRO for international biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client XWPharma on receiving positive results from its Phase 1…
Read More
July 2, 2021 in Company Video

Andy Hu on Avance Clinical – why it is the right CRO for Chinese Biotechs

Read More
June 24, 2021 in Company News

Avance Clinical Announces Appointment of Asia Biotech Specialist to Support APAC Growth

The leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical today announced the appointment of APAC expert Andy Hu as Business Development Manager…
Read More
June 20, 2021 in Company News

Avance Clinical’s USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results of their Australian Clinical Trials Knowledge Survey with Endpoints News as…
Read More
June 18, 2021 in Conference News

Avance Clinical at ARCS 2021 Conference

The Avance Clinical team attended the ARCS Annual Conference this week for in-person industry meetings.
Read More
June 10, 2021 in Company News

TrialTrove Data Shows Australia is Open for Business says Avance Clinical at BIO Digital 2020

The leading Australian CRO for biotechs, Avance Clinical announced at BIO Digital today that Australia currently has 2,413 trials planned or ongoing. Importantly in Australia, despite the global COVID-19 pandemic,…
Read More
June 6, 2021 in Company News, Conference News

Avance Clinical’s USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results of their Australian Clinical Trials Knowledge Survey with Endpoints News as…
Read More
May 29, 2021 in Company News, Conference News

Avance Clinical Releases Industry Survey Results at BIO Korea 2021 – Data Quality the Top Criteria for Selecting a CRO

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical shared results of a recent industry survey conducted by the company that found data…
Read More
May 21, 2021 in Company Awards, Company News

Avance Clinical Wins Excellence in Business Award 2021

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical has won the Fast Movers SA Excellence in Business Award 2021 sponsored by international accounting and business advisory…
Read More
May 6, 2021 in Company Awards, Company News

Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded its gene technology clinical trial services to meet the increasing global demand…
Read More
April 22, 2021 in Company News, Partner News

Avance Clinical Invited to Present “Decentralized Trials – No Going Back” for Oracle Health Sciences Connect

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been invited to present on the future of decentralized clinical trials at the Oracle…
Read More
March 14, 2021 in Client News

Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical congratulated Atossa Therapeutics on the announcement of their Phase 1 final results for the…
Read More
March 2, 2021 in Uncategorized

Avance Clinical Joins Industry Leaders at Conference Discussing The Future of Medicinal Cannabis

Australian CRO Avance Clinical Chief Scientific Officer joins industry leaders and Federal Health Minister Greg Hunt today at a conference discussing research opportunities in the fast-growing medicinal cannabis therapeutics sector…
Read More
February 9, 2021 in Company News

Avance Clinical Featured in Endpoints News

Is Australia the next Global Destination for Phase 2? According to TrialTrove, there have been 1,411 industry sponsored clinical trials recruiting in Australia and New Zealand since 2019, with 330…
Read More
January 5, 2021 in Company News

COVID-19 and the APAC CRO Landscape | Avance Clinical featured in Biospectrum Asia

“Australia has been recognized globally for its handling of the COVID-19 pandemic with strict quarantine systems and advanced contact tracing, resulting in low numbers of cases and deaths. Therefore we…
Read More
December 18, 2020 in Company News, Partner News

News: Avance Clinical Adds Oracle Argus Safety and Pharmacovigilance Platform to its Clinical Technology Solutions

The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner, Avance Clinical has further enhanced its innovative clinical research technology solutions with the addition of…
Read More
December 11, 2020 in Company Awards, Company News

AUSTRALIA & ASIA-PACIFIC CRO MARKET REPORT: Frost & Sullivan

Avance Clinical has positioned itself as a global leader in early phase clinical trials by developing innovative strategies and approaches to initial phase development. It helps global biotech companies set…
Read More
November 10, 2020 in Company News

ENDPOINTS NEWS: How Innovative Technologies and a Dedicated Site Network is Driving Patient Recruitment for Biotech Clinical Trials in Australia

Australia’s CRO for biotechs, Avance Clinical, deep dives into the patient recruitment landscape identifying the mechanisms and processes that deliver exceptional patient recruitment for early phase trials in Australia. Avance…
Read More
November 3, 2020 in Client News, Company News

Avance Clinical Client Atossa Therapeutics Completes Enrollment of Phase 1 Clinical Study of AT-301 Nasal Spray Being Developed for the Coronavirus Causing COVID

The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical is pleased to share the news that their client Atossa Therapeutics (NASDAQ: ATOS)…
Read More
October 30, 2020 in Company Awards, Company News

Avance Clinical Wins MasterControl 2020 Innovation Excellence Award

The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner, Avance Clinical today accepted the MasterControl 2020 Innovation Excellence Award in a virtual ceremony. Avance Clinical made…
Read More
October 8, 2020 in Company News, Partner News

Biotechs get scalable early to late phase clinical offering from Cromos Pharma and Avance Clinical collaboration in Australia and Europe

Dublin/Ireland – Adelaide/Australia – Two dominant regional contract research organizations (CRO), Avance Clinical and Cromos Pharma, with operations in Australia and Central/Eastern Europe, respectively, are successfully collaborating on a scalable…
Read More
October 1, 2020 in Company News

News: Avance Clinical ‘ClinicReady’ Featured in Endpoints News

How ClinicReady by Australian CRO Avance Clinical delivers preclinical project management and scientific and regulatory advice to get biotechs into clinic faster Read the full article here
Read More
September 22, 2020 in Company News, Conference News, Partner News

Avance Clinical Announces Expanded eClinical Solutions for Biotech Clinical Trials at BioPharm America

The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner, Avance Clinical has expanded its eClinical solutions offering, with advanced digital clinical tools for enhanced…
Read More
September 13, 2020 in Company News

News: Jorgen Mould PhD, BSc (Hons) joins Avance Clinical as Scientific Affairs Specialist

The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical is pleased to announce the appointment of Jorgen Mould PhD, BSc (Hons) as…
Read More
September 4, 2020 in Client News, Company News

Avance Clinical Client Immunic, Inc. Announced Dosing of First Healthy Volunteer in Phase 1 Clinical Program of IMU-856, Targeting Restoration of Intestinal Barrier Function

The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical is pleased to share the news that its client Immunic Therapeutics has announced…
Read More
August 27, 2020 in Client News, Company News

Avance Clinical Client Atossa Therapeutics Announces Enrollment and Dosing Completed in First Group of Healthy Participants in Clinical Study of AT-301 Nasal Spray Being Developed for Treatment of COVID-19

  The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical is pleased to share the news that Atossa Therapeutics have enrolled and…
Read More
August 12, 2020 in Uncategorized

Mike Watson Appointed Avance Clinical Director, Business Development, USA

Mike Watson has joined Avance Clinical as Director, Business Development, USA. It is our pleasure to announce that Mike Watson has joined the Avance Clinical team as Director Business Development,…
Read More
July 30, 2020 in Company News, Partner News

Avance Clinical Joins Medrio’s ‘Trial Talks’ Podcast about Why Clinical Trials are Thriving in Australia

The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical, joins Medrio’s new podcast series Trial Talks (listen here https://medrio.com/podcast/why-clinical-trials-are-thriving-in-australia/). Medrio, Inc. is the leading provider…
Read More
July 22, 2020 in Client News, Company News

Avance Clinical Contracted for Atossa Therapeutics AT-301 Nasal Spray Clinical Study, Atossa’s Second COVID-19 Therapeutic Development Program

The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been contracted to conduct a clinical study of Atossa Therapeutics’ proprietary drug…
Read More
July 13, 2020 in Company Awards

Soniclean is proud to announce Avance Clinical as the winner of the International Health Award at the Business SA 2019 Export Awards

As a major sponsor, Soniclean is thrilled to be able to celebrate South Australian exporting excellence by sponsoring the International Health Award and its recognition of Avance Clinical, which progresses…
Read More
July 8, 2020 in Company Awards, Company News

Avance Clinical Wins Frost & Sullivan “2020 Asia-Pacific CRO Market Leadership Award”

Adelaide, Australia – The leading Australian CRO for biotechs, Avance Clinical, accepted the prestigious Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award at a global virtual awards ceremony overnight. According to Frost…
Read More
June 1, 2020 in Company News

Premier of South Australia Steven Marshall Briefed on $50 billion Clinical Trial Sector During Visit to Adelaide-based Avance Clinical

The leading Australian CRO for biotechs, Avance Clinical, hosted a visit with the Premier of South Australia the Hon. Steven Marshall MP to discuss the fast-growing clinical trials sector, currently…
Read More
May 26, 2020 in Company News

Endpoints News: About Avance Clinical’s Oncology Capabilities

How Australia Delivers Rapid Start-up and 43.5% Rebate for Early Phase Oncology Trials See the full article here
Read More
May 12, 2020 in Company News

Avance reports 34% rise in clinical trials in Australia and New Zealand

Avance Clinical, which has been offering CRO services for more than two decades for early phase trials, reports 95 new trials were registered in the past 30 days as recorded…
Read More
April 10, 2020 in Company News

Australian CRO Avance Clinical Designated an Essential Service as Strong Demand from Sponsors Continues Amid COVID-19 Crisis

Leading Australian CRO Avance Clinical said there was still strong demand from Asian and US sponsors, and commended Australian sites that had risen to the challenge to deliver for Avance…
Read More
March 24, 2020 in Company Video

About Avance Clinical COVID-19 capabilities

Read More